Retrospective cohort study finds structured mobilization enhances functional status in patients with axillary pVADs, indicating its feasibility and effectiveness.
Axillary percutaneous ventricular assist devices (pVADs) are increasingly utilized for refractory cardiogenic shock, yet standardized mobilization protocols are lacking. This study describes a structured mobilization protocol and evaluates its implementation in 196 patients supported with an axillary pVAD from December 2020 to June 2025. Of this cohort, 131 (67%) were mobilized per a progressive multidisciplinary exercise protocol. Mobilized patients achieved significantly higher functional status by intensive care unit (ICU) discharge via Johns-Hopkins Highest Level of Mobility (JH-HLM) scoring (p < 0.001) and hospital discharge (p = 0.002). Longitudinal analysis demonstrated significant stepwise improvement in JH-HLM scores across sessions (p < 0.001) with statistical gains appearing as early as the third session (p < 0.001). Stratified analysis confirmed feasibility across all clinical outcomes, including recovery (p = 0.002), durable left ventricular assist device (LVAD) (p < 0.001), and heart transplant (p = 0.023). Regarding clinical outcomes, the mobilized cohort had a lower mortality rate (12% vs. 58%), higher rates of myocardial recovery (46% vs. 25%), durable LVAD implantation (21% vs. 9%), and heart transplantation (20% vs. 8%) (p < 0.001). This technical report details a safe, reproducible framework for patients with axillary pVAD support, showing that a structured mobilization protocol is feasible and associated with progressive improvement in functional status.
No takes yet. Share an insight, caveat, or question.
Modi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: